Document:

Exhibit
10.1

AMENDED
STOCK OPTION AGREEMENT

STOCK
OPTION AGREEMENT (the “Agreement”), amending the original agreement dated as of
[ ], between BrandPartners Group, Inc., a Delaware corporation (the “Company”),
having an address at 10 Main Street, Rochester NH 03839 and
______________________________ (“Grantee”) having an address at
____________________.

WHEREAS
the Company has previously granted to Grantee for services provided by Grantee
to the Company as a director certain options to purchase shares of common stock,
$0.01 par value of the Company under the Company’s 2001 Stock Incentive Plan
(the “Plan”); 

WHEREAS
the Grantee has agreed to surrender certain options as previously granted under
the Plan;

WHEREAS
the Company has agreed to accept the surrender by Grantee of certain options
previously granted to Grantee under the Plan;

WHEREAS
the Company has agreed to provide Grantee the right to exercise the remaining
options granted to Grantee under the Plan by way of a “cashless exercise”;

WHEREAS,
the Company has further agreed to register the shares of common stock underlying
the Plan; and

WHEREAS,
the Company and Grantee wish to set forth the terms related to the surrender of
options by the Grantee and the Company’s modification of the terms of the
options.

NOW
THEREFORE, IN CONSIDERATION OF THE 

PREMISES
AND THE MUTUAL PROMISES SET FORTH 

HEREIN,
THE PARTIES HERETO AGREE AS FOLLOWS:

 

1. Surrender
of Options. The
Company and Grantee hereby evidence and confirm that [ ] options to purchase
common stock of the Company (the “Original Options”) were granted to Grantee on
[ ] under the Plan and that Grantee hereby agrees to surrender [ ] of the
Original Options effective the date of this Agreement in turn leaving Grantee [
] options (the “Remaining Options”).

2. Exercise
Price of Remaining Options. The
exercise price of the Remaining Options will remain unchanged at $[
] per
share.

3. Term
and Vesting of Remaining Option. The
term of the Remaining Options shall remain unchanged from the date of original
grant and will expire [ ]. The vesting of Remaining Options shall remain
unchanged from the vesting provided for the Original Options. 

4. Exercise
of Remaining Options. The
Remaining Options may be exercised by written notice to the Chief Executive
Officer of the Company at the Company’s principal office. Such notice shall
state the election to exercise the Remaining Options and the number of shares in
respect of which it shall be exercised, and shall be signed by the person or
persons exercising the Remaining Options. In the event that the Remaining
Options shall be exercised pursuant to Paragraph 6 hereof by any person other
than the Grantee, such notice shall be accompanied by appropriate proof of the
right of such person to exercise the Remaining Option, as may be reasonably
required by the Company and its counsel. Subject to Paragraph 5, the notice of
exercise shall be accompanied by payment of the full purchase price of the
Shares, being purchased in cash or cash equivalents. The certificate or
certificates for the shares as to which the Remaining Option shall have been so
exercised shall be issued in the name of the Grantee and shall be delivered, as
provided above, to or upon the written order of the person or persons exercising
the Remaining Option as soon as practicable (except as otherwise provided below
in this Paragraph 4) after the due and proper exercise of the Remaining Options.
The Remaining Options will be deemed exercised on the date the above-described
notice and payment are hand delivered or, if mailed, postmarked. The holder of
the Remaining Options shall not have any rights of a stockholder with respect to
the shares covered by the Remaining Option unless and until the certificate or
certificates for such shares shall have been issued and delivered. It is
expressly understood that, notwithstanding anything contained in this Agreement
to the contrary, (i) the time for the delivery of the certificate or
certificates of Common Stock may be postponed by the Company for such period as
may be required by the Company to comply with any applicable State or Federal
law or the requirements of a Self Regulatory Organization, and (ii) unless and
until the Shares underlying the Remaining Option are subject to an effective
registration statement, the Shares delivered upon exercise of the Remaining
Option will be subject to certain restrictions on transfer. 

5. Cashless
Exercise. In
consideration of the Grantee’s surrender of a portion of the Original Options,
the Company hereby provides Grantee in accord with the Plan the ability to
exercise the Remaining Options by way of a cashless exercise using the following
formula:

X=Y
(A-B)

    
A

 

	 	
      Where
	
      X=
	
      the
      number of shares of Common Stock to be issued to the holder under the
      Option

 

Y= the
number of shares of Common Stock purchasable under the Option or, if only a
portion of the Option is being exercised, the portion of the Option being
exercised (at the date of such calculation)

 

A= the
average Fair Market Value of the Company’s Common Stock based on the closing
sales price of the Common Stock on the Over the Counter Bulletin Board Market or
comparable domestic securities exchange should the Company’s Common Stock be so
listed, averaged over a period of 21 trading days immediately prior to the day a
notice of exercised is faxed to the Company

 

B= Exercise
Price of Option

 

6. Nontransferability. The
Remaining Option may be exercised only by the Grantee, and may not be assigned,
pledged, or otherwise transferred except as provided below. During the Grantee’s
lifetime, the Grantee’s Option may be transferred to (i) his or her spouse,
children or grandchildren (“Immediate Family Members”), (ii) a trust or trusts
for the exclusive benefit such Immediate Family Members, or (iii) a partnership
in which such Immediate Family Members are the only partners, provided that (x)
there may be no consideration for any such transfer and (y) subsequent transfers
of the transferred Option shall be prohibited except those by will or the laws
of descent and distribution. Following any such transfer, the Remaining Option
shall continue to be subject to the same terms and conditions as were applicable
immediately prior to transfer. In the event the Grantee is incapacitated, the
Remaining Option may be exercised by the Grantee’s guardian or legal
representative. In the event of the Grantee’s death, the Remaining Option may be
exercised by the executor or administrator of the Grantee’s estate or by a
person who acquired the right to exercise them by bequest or inheritance or by
reason of the Grantee’s death.

7. Adjustments. In the
event of any merger, reorganization, consolidation, sale of substantially all
assets, recapitalization, reclassification, Common Stock dividend (in excess of
5% thereon), Common Stock split or reverse split, spin-off, split-up, split-off,
distribution of assets or other change in corporate structure affecting the
Common Stock after the date hereof, an appropriate substitution or adjustment
shall be made in the number of shares subject to the Remaining Option and to the
exercise price; provided, however, that such adjustment shall not increase the
aggregate value of the option, no fractional shares shall be issued, and the
aggregate exercise price shall be appropriately reduced on account of any
fractional shares. Without limiting the foregoing, in case of any consolidation
or merger of the Company with or into another corporation (other than a merger
with a subsidiary in which the Company is the continuing corporation and which
does not result in any reclassification, capital reorganization or other change
of the outstanding Shares issuable upon exercise of the Remaining Option) or in
case of the sale, transfer or other disposition of all or substantially all of
the assets of the Company, then the Grantee shall be entitled to receive upon
exercise of the Remaining Option such number of shares of capital stock or other
securities or property upon, or as a result of, such transaction that the
Grantee would have been entitled to receive had the Remaining Option been
exercised immediately prior to such transaction.

 

8. No
Limitation on Rights of the Company. The
amendment and surrender of options and the Remaining Options shall not in any
way affect the right or power of the Company to make adjustments,
reclassifications, or changes in its capital or business structure or to merge,
consolidate, dissolve, liquidate, sell, or transfer all or any part of its
business or assets.

9. Rights
as a Stockholder. The
Grantee shall have the rights of a stockholder with respect to the Shares
covered by the Remaining Option only upon becoming the holder of record of those
Shares.

10. No
Obligation to Exercise Remaining Option. The
Grantee shall be under no obligation to exercise the Remaining
Option.

11. Governing
Law. Except
to the extent preempted by Federal law, this Agreement shall be construed and
enforced in accordance with, and governed by, the laws of the State of New York
without regard to any rules regarding conflicts of law.

IN
WITNESS WHEREOF, the Company and the Grantee have duly executed this Stock
Option Agreement as of the date first above written.

	 	BRANDPARTNERS GROUP, INC.
	 	 
	 	By:
	 	Name: 
	 	Title: 
	 	 
	 	[NAME OF GRANTEE]EMPLOYMENT AGREEMENT

                      THIS AGREEMENT DATED JANUARY 1, 2004

                                    BETWEEN:

                                 Organetix, Inc.
    (hereinafter referred to as "ORG" and which has as its business address:
                            Suite 200, 603-7th Ave SW
                                Calgary, Alberta
                                    T2P 2T5)

                                       and

                             MR. L.B. (Brad) CLARKE
                    (hereinafter referred to as "Clarke" who
                                   resides at:
                            132 Silvergrove Manor NW
                                Calgary, Alberta
                                    T3B 5K6)

The following will outline the terms and conditions of Clarke's employment with
ORG ("the Agreement").

(1)   Clarke will be employed by ORG as a senior executive in ORG to undertake
      work assigned to the job generally described by the title:

                  Chairman, President & CEO ("the Position").

(2)   Attached hereto as Appendix I, is an outline of the general scope of work,
      duties and responsibilities ("the Job Description") for the Position. ORG
      reserves the right in its absolute discretion to alter work assignments,
      change responsibilities or assign new work, not described in the Job
      Description, where deemed by ORG to be within Clarke's capability,
      training and aptitude.

(3)   The monthly salary associated with the Position (the "Salary") is
      $US10,000.00 (less any applicable withholding taxes) and Clarke shall
      receive no less than $US 10,000.00 per month for the term of this
      agreement. The Salary shall be paid monthly based on an Annual Salary of
      $US 120,000.00. Clarke has the sole option to reduce the monthly Salary on
      a month to month basis based on ORG's financial capabilities and or
      exchange the Salary in part or in whole for common shares and or stock
      options and or warrants when agreed to by Clarke and the Board of
      Directors of ORG at the fair market value at the date of exchange.

(4)   The Salary and Job Description shall be reviewed by December 31, 2004 and
      annually upon the anniversary date of this Agreement ("the Anniversary
      Date"). For purposes of clarity, the agreed upon Salary for Clarke for the
      year 2005 is agreed to be a minimum of $US 15,000.00 per month and for
      2006 is agreed to be a minimum of $US 20,000.00 per month. The Salary may
      be adjusted upward based upon Clarke's performance as evaluated and
      approved by ORG's Board of Directors. ORG will implement a Performance &
      Profit Sharing Plan ("the Incentive Plan") and Clarke will participate in
      the Incentive Plan and will be eligible to receive performance cash
      payments, stock options and other performance incentives assigned to the
      Position from the Incentive Plan.

                                       1
<PAGE>

(5)   When Clarke reaches the deemed maximum Salary for the position, a yearly
      cash performance bonus may be granted where recommended by and supported
      by ORG's Board of Directors.

(6)   At such time as ORG implements a medical and dental benefit plan ("the
      Benefit Plan"), Clarke will be eligible to receive benefits that ORG will
      assign to the Position providing Clarke meets the minimum qualifying
      criteria as defined in the Benefit Plan. Clarke will be obligated to
      participate in those group benefits defined in the Benefit Plan where 100%
      coverage is mandatory.

(7)   Clarke will receive Statutory Holidays, Personal leave and any other
      personal benefits as defined by the Board. The exception shall be vacation
      entitlement where Clarke will receive a special benefit of 6 weeks (30
      work days) annual vacation with pay. For the purposes of vacation
      entitlement, entitlement shall be allotted annually based upon the
      calendar year, and Clarke's remaining entitlement for 2003 shall be the
      prorated annual balance of the number of vacation days described herein
      commencing on the date of this Agreement.

(8)   Clarke shall report to work at times and locations ("the Place of Work")
      prescribed by ORG and Clarke will establish the Place of Work.

(9)   The Position is a senior executive position and will not be eligible for
      overtime payments. Clarke acknowledges assignments may require work time
      outside normal working hours and beyond a 40 hour work week. ORG
      acknowledges Clarke has personal and family business interests outside of
      ORG ("Outside Interests") which will require his time and attention.
      Clarke pledges to organize his time and schedule so as functions, time and
      work at ORG receives first priority, and to provide continuous contact
      details so as to be available to the Board and staff at all reasonable
      times when away from ORG. Clarke further pledges his ability to perform
      ORG assigned duties and meet ORG assigned due dates shall not be affected
      by his Outside Interests.

(10)  ORG will provide Clarke with all administrative equipment and supplies
      necessary to complete assigned duties and shall reimburse or supply Clarke
      with equipment where deemed necessary by ORG to complete assigned work.
      Clarke will be obligated to use safety equipment provided where mandated
      by ORG and shall save ORG harmless from any injury or damage which may be
      incurred from failure to use safety equipment.

(11)  Clarke shall maintain expense sheets in the format, on the forms and on
      the schedules prescribed by ORG.

(12)  Clarke will be reimbursed for approved expenses incurred while carrying
      out assignments on behalf of ORG. In addition, Clarke shall receive a Car
      Allowance of $US 700.00 per month, and this Allowance shall be full and
      complete compensation for auto expenses incurred by Clarke in conducting
      ORG's business.

(13)  If Clarke at any time by reason of illness or mental or physical
      disability be incapacitated in ORG's sole opinion, relying on the advice
      of a doctor qualified to practice medicine in the Province of Alberta,
      from performing the Job Description assigned to the Position, and the
      incapacity continues for a period of 90 days, and at the request of ORG,
      Clarke furnishes satisfactory evidence of the incapacity and the cause of
      it, the Employment Agreement shall immediately terminate and Clarke shall
      receive whatever disability benefits are available through the Benefit
      Plan.

                                       2
<PAGE>

(14)  The Employment Agreement may be terminated by either party as follows:

      (a)   by Clarke - at no time prior to December 31, 2006 unless termination
                        is mutually agreed between ORG and Clarke,

      (b)   by ORG -    in its absolute discretion, without any notice or pay in
                        lieu thereof, for Cause.For the purposes of this
                        Agreement, Cause shall include:

            (i)         cause as defined under common law;

            (ii)        if the employee is convicted of an indictable offense
                        that is of a kind that is related to the qualifications,
                        functions or duties of the employee and either the time
                        for making the appeal has expired without the appeal
                        having been made or the appeal has been finally disposed
                        of by the Courts or abandoned; or

            (iii)       if he is guilty of a material breach provided that the
                        employee has been provided with 20 days' notice of such
                        default under the Agreement (the "Default Notice") and
                        has not cured such default within the Default Notice
                        period.

      (c)   by ORG -    at no time prior to December 31, 2006 unless for Cause
                        as defined in Clause 14 (b), or termination is mutually
                        agreed between Clarke and ORG,

                        after December 31, 2006 upon delivering to Clarke 90
                        days written notice and the payment of severance equal
                        to 12 month's Salary amounting to the Salary being paid
                        per month at the date of notice.

(15)  Upon termination for Cause, Clarke shall immediately resign from the
      Position and any other appointments held in the name of ORG, and Clarke
      shall not be entitled to severance or compensation for loss of office or
      otherwise by reason of the termination.

(16)  Upon termination for any reason, any and all monetary benefits, assigned
      options or shares, or other contracted and/or accrued benefits or
      obligations ORG has with Clarke to the date of such termination, shall be
      the absolute property of and shall be payable to Clarke in accordance with
      the terms of contracts or agreements covering such accrued benefits.

(17)  As soon as economically feasible, ORG agrees to provide Directors and
      Officers insurance and insurance to cover public liability, product
      liability and errors and omissions insurance, which in no case shall be
      less than the insurance which a reasonable and prudent businessman
      carrying on a similar line of business would acquire. This insurance shall
      be placed with a reputable and financially secure insurance carrier, shall
      include Clarke, as additional insureds, and shall provide primary coverage
      with respect to the activities contemplated by this Agreement. Such policy
      shall include severability of interest and cross-liability clauses and
      shall provide that the policy shall not be cancelled or materially altered
      except upon at least 30 days written notice to Clarke. Clarke shall have
      the right to require reasonable amendments to the terms or the amount of
      coverage contained in the policy. Failing the parties agreeing on the
      appropriate terms or the amount of coverage, then the matter shall be
      determined by arbitration as provided for herein. The Licensee shall
      provide Clarke with certificates of insurance.

                                       3
<PAGE>

(18)  This Employment Agreement constitutes the entire agreement between the
      parties and there are no collateral agreements, warranties,
      representations or understandings, save as expressly contained herein.

(19)  Clarke shall be bound to the terms and conditions of confidentiality and
      non-disclosure.

(20)  No modification to the Employment Agreement will be binding unless
      attached hereto as an Attachment and signed by Clarke and a duly
      authorized officer of ORG.

(21)  This Agreement shall be governed and interpreted according to the laws of
      the Province of Alberta.

IN WITNESS WHEREOF, the parties hereto executed this Employment Agreement
effective the date indicated.

                                    ORGANETIX, INC.

Corporate Seal
                                    per: /s/ Steven Sanders
                                    Chairman of Organetix Compensation Committee

                                    Per: /s/ L. B. (Brad) Clarke
                                         -----------------------
                                             L.B. (Brad) Clarke

                                    Per: /s/ L. B. (Brad) Clarke
                                         -----------------------
                                             Lennox Resources Ltd.

                                       4
<PAGE>

                                   APPENDIX I

                                 JOB DESCRIPTION

for:     L.B.(Brad) Clarke (hereinafter referred to as Clarke)

                    Position Title: CHAIRMAN, PRESIDENT & CEO

Clarke shall perform the duties of Chairman, President & CEO being generally
described as follows:

Reporting to the Board, Clarke will:

1.    Assume direct responsibility for achieving ORG's Business Plan and
      Financial Plan, and proposing amendments to the Plans as deemed necessary
      based upon the organization's performance and changes in market
      conditions.

2.    Prepare reports as required by the Board summarizing ORG's progress
      relating to the Business Plan and the Financing Plan.

3.    Prepare ORG's short term and long term staffing plan and secure Board
      approvals, propose organizational structures, establish job descriptions,
      initiate recruitment and participate in the interview and selection
      process.

4.    Set goals and objectives for ORG's staff, on a quarterly basis, and
      provide advice, direction and guidance to ORG's staff to assist in
      achieving defined goals and objectives.

5.    Develop budget proposals for the Board's review and approval, allocate
      approved budgets to ORG's staff, monitor expenditures and staff's
      performance in meeting budget targets, approve requests for funds, propose
      amendments to budgets and/or the Financing Plan and prepare documentation
      as required to seek Board approval to amend the Financing Plan.

6.    Review staff's performance in achieving short term and long term goals and
      objectives as delegated from the Business Plan and the Financial Plan, or
      as amended by the Board, and recommend the granting of options, bonuses,
      non-monetary incentives, profit sharing and other rewards to staff as
      assigned to ORG by ORG's Board.

7.    Assist in preparing, implementing and monitoring the advertising,
      promotion, and investor relations program (the "Public Relations Program")
      to present and expose ORG's products to the widest possible customer base,
      and represent ORG when required for investor, public and media relations
      when asked to do so by the Board or when called for in the Public
      Relations Program.

                                       5
<PAGE>

8.    Develop and propose marketing and sales strategies and assist in
      implementing strategic sales and marketing plans to maximize revenue and
      profit from the sale of ORG's products or services, to penetrate new
      markets and to introduce new products and/or services.

9.    Establish and assist ORG's Executive Committee.

10.   Evaluate new potential products, technology, additives, suppliers,
      applications and potential product improvements recommended by staff,
      customers or other end-users, make recommendations to the Board concerning
      their marketability and feasibility, and budget, direct and coordinate
      trials, tests and research to evaluate improvements and to keep ORG one
      step ahead of the competition. Evaluate and plan potential treatment
      clinics in Punta Cana, DR and or Mexico.

11.   Keep informed about industry developments, the competition, new
      technology, new products and new ideas by attending trade shows,
      exhibitions and conferences and by reviewing industry publications, news
      articles, association journals, research reports and other documentation,
      and by strategic networking.

12.   Assist in identifying, evaluating and proposing target corporate or
      technology acquisitions for ORG and ORG to diversify product lines and
      maximize profitability.

13.   Oversee all the research, patents, clinical trials, and Peru operations.

Perform other corporate and administrative functions as may be assigned or
requested by the Board.

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]